Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Phase 2 Unknown
Dietary Soy Isoflavones for the Prevention of Cancer
Phase NA Unknown
90 enrolled
PNU 166148 in Treating Patients With Metastatic Solid Tumors
Phase 1 Unknown
30 enrolled
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid Tumors
Phase 1 Unknown
20 enrolled
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
Phase 1/2 Unknown
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
Phase 1/2 Unknown
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Phase 3 Unknown
300 enrolled
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
Phase 1 Unknown
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
Phase 1 Unknown
Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations
Phase NA Unknown
2,619 enrolled
Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Phase NA Unknown
20 enrolled
Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet
Phase NA Unknown
2,520 enrolled
Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye
Phase NA Unknown
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
Unknown
60 enrolled
Pharmacokinetics of Dactinomycin in Young Patients With Cancer
Unknown
50 enrolled
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
Phase 1 Unknown
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
Phase 2 Unknown
Effect of Bevacizumab and VEGF on Platelet Clustering in Patients Who Are Receiving Bevacizumab for Cancer
Unknown
20 enrolled
Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer
Phase 1 Unknown
Combination Chemotherapy in Treating Patients With Solid Tumors
Phase 1 Unknown
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
Unknown
270 enrolled
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
Phase NA Unknown
670 enrolled
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
Phase 1/2 Unknown
30 enrolled
BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment
Phase 1 Unknown